[Hypertrophic myopathy due to muscular metastasis of a signet cell adenocarcinoma of the bladder].
Brénuchon
C
C
Launay
D
D
Maurage
C A
CA
Queyrel
V
V
Lambert
M
M
N'Guyen
H D
HD
Boutry
N
N
Hachulla
E
E
Hatron
P Y
PY
Devulder
B
B
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002081:Buttocks; D018279:Carcinoma, Signet Ring Cell / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D006984:Hypertrophy / Q000209:etiology; D008297:Male; D019042:Muscle Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D018482:Muscle, Skeletal / Q000473:pathology*; D009135:Muscular Diseases / Q000209:etiology; D009364:Neoplasm Recurrence, Local; D013848:Thigh; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000473:pathology*; D000093542:Gemcitabine
D000305:Adrenal Cortex Hormones; D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine